The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Clinical Trial Imaging Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Global Clinical Trial Imaging Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1646374

No of Pages : 112

Synopsis
The global Clinical Trial Imaging market size was valued at USD 1413.1 million in 2022 and is forecast to a readjusted size of USD 2215.1 million by 2029 with a CAGR of 6.6% during review period.

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

The Global Info Research report includes an overview of the development of the Clinical Trial Imaging industry chain, the market status of Pharmaceutical Companies (In-house Imaging Service, Central Imaging Service), Biotechnology Companies (In-house Imaging Service, Central Imaging Service), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Clinical Trial Imaging.

Regionally, the report analyzes the Clinical Trial Imaging markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Clinical Trial Imaging market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Clinical Trial Imaging market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Clinical Trial Imaging industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., In-house Imaging Service, Central Imaging Service).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Clinical Trial Imaging market.

Regional Analysis: The report involves examining the Clinical Trial Imaging market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Clinical Trial Imaging market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Clinical Trial Imaging:

Company Analysis: Report covers individual Clinical Trial Imaging players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Clinical Trial Imaging This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Biotechnology Companies).

Technology Analysis: Report covers specific technologies relevant to Clinical Trial Imaging. It assesses the current state, advancements, and potential future developments in Clinical Trial Imaging areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Clinical Trial Imaging market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Clinical Trial Imaging market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type

  • In-house Imaging Service
  • Central Imaging Service

Market segment by Application

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others

Market segment by players, this report covers

  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Clinical Trial Imaging product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Trial Imaging, with revenue, gross margin and global market share of Clinical Trial Imaging from 2018 to 2023.
Chapter 3, the Clinical Trial Imaging competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Trial Imaging market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Trial Imaging.
Chapter 13, to describe Clinical Trial Imaging research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Clinical Trial Imaging
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Clinical Trial Imaging by Type
1.3.1 Overview: Global Clinical Trial Imaging Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Clinical Trial Imaging Consumption Value Market Share by Type in 2022
1.3.3 In-house Imaging Service
1.3.4 Central Imaging Service
1.4 Global Clinical Trial Imaging Market by Application
1.4.1 Overview: Global Clinical Trial Imaging Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Companies
1.4.3 Biotechnology Companies
1.4.4 Academic Institutes
1.4.5 Others
1.5 Global Clinical Trial Imaging Market Size & Forecast
1.6 Global Clinical Trial Imaging Market Size and Forecast by Region
1.6.1 Global Clinical Trial Imaging Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Clinical Trial Imaging Market Size by Region, (2018-2029)
1.6.3 North America Clinical Trial Imaging Market Size and Prospect (2018-2029)
1.6.4 Europe Clinical Trial Imaging Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Clinical Trial Imaging Market Size and Prospect (2018-2029)
1.6.6 South America Clinical Trial Imaging Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Clinical Trial Imaging Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 ICON
2.1.1 ICON Details
2.1.2 ICON Major Business
2.1.3 ICON Clinical Trial Imaging Product and Solutions
2.1.4 ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ICON Recent Developments and Future Plans
2.2 ERT
2.2.1 ERT Details
2.2.2 ERT Major Business
2.2.3 ERT Clinical Trial Imaging Product and Solutions
2.2.4 ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ERT Recent Developments and Future Plans
2.3 McLaren
2.3.1 McLaren Details
2.3.2 McLaren Major Business
2.3.3 McLaren Clinical Trial Imaging Product and Solutions
2.3.4 McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 McLaren Recent Developments and Future Plans
2.4 Bioclinica
2.4.1 Bioclinica Details
2.4.2 Bioclinica Major Business
2.4.3 Bioclinica Clinical Trial Imaging Product and Solutions
2.4.4 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bioclinica Recent Developments and Future Plans
2.5 Parexel
2.5.1 Parexel Details
2.5.2 Parexel Major Business
2.5.3 Parexel Clinical Trial Imaging Product and Solutions
2.5.4 Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Parexel Recent Developments and Future Plans
2.6 BioTelemetry
2.6.1 BioTelemetry Details
2.6.2 BioTelemetry Major Business
2.6.3 BioTelemetry Clinical Trial Imaging Product and Solutions
2.6.4 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioTelemetry Recent Developments and Future Plans
2.7 ProScan Imaging
2.7.1 ProScan Imaging Details
2.7.2 ProScan Imaging Major Business
2.7.3 ProScan Imaging Clinical Trial Imaging Product and Solutions
2.7.4 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ProScan Imaging Recent Developments and Future Plans
2.8 Imaging Endpoints
2.8.1 Imaging Endpoints Details
2.8.2 Imaging Endpoints Major Business
2.8.3 Imaging Endpoints Clinical Trial Imaging Product and Solutions
2.8.4 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Imaging Endpoints Recent Developments and Future Plans
2.9 Radiant Sage
2.9.1 Radiant Sage Details
2.9.2 Radiant Sage Major Business
2.9.3 Radiant Sage Clinical Trial Imaging Product and Solutions
2.9.4 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Radiant Sage Recent Developments and Future Plans
2.10 Micron, Inc.
2.10.1 Micron, Inc. Details
2.10.2 Micron, Inc. Major Business
2.10.3 Micron, Inc. Clinical Trial Imaging Product and Solutions
2.10.4 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Micron, Inc. Recent Developments and Future Plans
2.11 Intrinsic Imaging
2.11.1 Intrinsic Imaging Details
2.11.2 Intrinsic Imaging Major Business
2.11.3 Intrinsic Imaging Clinical Trial Imaging Product and Solutions
2.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Intrinsic Imaging Recent Developments and Future Plans
2.12 Median Technologies
2.12.1 Median Technologies Details
2.12.2 Median Technologies Major Business
2.12.3 Median Technologies Clinical Trial Imaging Product and Solutions
2.12.4 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Median Technologies Recent Developments and Future Plans
2.13 Cardiovascular Imaging Technologies
2.13.1 Cardiovascular Imaging Technologies Details
2.13.2 Cardiovascular Imaging Technologies Major Business
2.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Product and Solutions
2.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cardiovascular Imaging Technologies Recent Developments and Future Plans
2.14 Banook Medical
2.14.1 Banook Medical Details
2.14.2 Banook Medical Major Business
2.14.3 Banook Medical Clinical Trial Imaging Product and Solutions
2.14.4 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Banook Medical Recent Developments and Future Plans
2.15 IXICO
2.15.1 IXICO Details
2.15.2 IXICO Major Business
2.15.3 IXICO Clinical Trial Imaging Product and Solutions
2.15.4 IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IXICO Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Clinical Trial Imaging Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Clinical Trial Imaging by Company Revenue
3.2.2 Top 3 Clinical Trial Imaging Players Market Share in 2022
3.2.3 Top 6 Clinical Trial Imaging Players Market Share in 2022
3.3 Clinical Trial Imaging Market: Overall Company Footprint Analysis
3.3.1 Clinical Trial Imaging Market: Region Footprint
3.3.2 Clinical Trial Imaging Market: Company Product Type Footprint
3.3.3 Clinical Trial Imaging Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Clinical Trial Imaging Consumption Value and Market Share by Type (2018-2023)
4.2 Global Clinical Trial Imaging Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Clinical Trial Imaging Consumption Value Market Share by Application (2018-2023)
5.2 Global Clinical Trial Imaging Market Forecast by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Imaging Consumption Value by Type (2018-2029)
6.2 North America Clinical Trial Imaging Consumption Value by Application (2018-2029)
6.3 North America Clinical Trial Imaging Market Size by Country
6.3.1 North America Clinical Trial Imaging Consumption Value by Country (2018-2029)
6.3.2 United States Clinical Trial Imaging Market Size and Forecast (2018-2029)
6.3.3 Canada Clinical Trial Imaging Market Size and Forecast (2018-2029)
6.3.4 Mexico Clinical Trial Imaging Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Clinical Trial Imaging Consumption Value by Type (2018-2029)
7.2 Europe Clinical Trial Imaging Consumption Value by Application (2018-2029)
7.3 Europe Clinical Trial Imaging Market Size by Country
7.3.1 Europe Clinical Trial Imaging Consumption Value by Country (2018-2029)
7.3.2 Germany Clinical Trial Imaging Market Size and Forecast (2018-2029)
7.3.3 France Clinical Trial Imaging Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Clinical Trial Imaging Market Size and Forecast (2018-2029)
7.3.5 Russia Clinical Trial Imaging Market Size and Forecast (2018-2029)
7.3.6 Italy Clinical Trial Imaging Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Imaging Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Clinical Trial Imaging Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Clinical Trial Imaging Market Size by Region
8.3.1 Asia-Pacific Clinical Trial Imaging Consumption Value by Region (2018-2029)
8.3.2 China Clinical Trial Imaging Market Size and Forecast (2018-2029)
8.3.3 Japan Clinical Trial Imaging Market Size and Forecast (2018-2029)
8.3.4 South Korea Clinical Trial Imaging Market Size and Forecast (2018-2029)
8.3.5 India Clinical Trial Imaging Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Clinical Trial Imaging Market Size and Forecast (2018-2029)
8.3.7 Australia Clinical Trial Imaging Market Size and Forecast (2018-2029)
9 South America
9.1 South America Clinical Trial Imaging Consumption Value by Type (2018-2029)
9.2 South America Clinical Trial Imaging Consumption Value by Application (2018-2029)
9.3 South America Clinical Trial Imaging Market Size by Country
9.3.1 South America Clinical Trial Imaging Consumption Value by Country (2018-2029)
9.3.2 Brazil Clinical Trial Imaging Market Size and Forecast (2018-2029)
9.3.3 Argentina Clinical Trial Imaging Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Imaging Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Clinical Trial Imaging Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Clinical Trial Imaging Market Size by Country
10.3.1 Middle East & Africa Clinical Trial Imaging Consumption Value by Country (2018-2029)
10.3.2 Turkey Clinical Trial Imaging Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Clinical Trial Imaging Market Size and Forecast (2018-2029)
10.3.4 UAE Clinical Trial Imaging Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Clinical Trial Imaging Market Drivers
11.2 Clinical Trial Imaging Market Restraints
11.3 Clinical Trial Imaging Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Clinical Trial Imaging Industry Chain
12.2 Clinical Trial Imaging Upstream Analysis
12.3 Clinical Trial Imaging Midstream Analysis
12.4 Clinical Trial Imaging Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’